Literature DB >> 25046649

Alternative quality assessment strategy to compare performances of GPCR-ligand docking protocols: the human adenosine A(2A) receptor as a case study.

Antonella Ciancetta1, Alberto Cuzzolin, Stefano Moro.   

Abstract

The progress made in the field of G protein-coupled receptors (GPCRs) structural determination has increased the adoption of docking-driven approaches for the identification or optimization of novel potent and selective ligands. In this work, we compared the performances of the 16 different docking/scoring combinations using the recently released crystal structures of the human A2A AR (hA2A AR) in complex with both agonists and antagonists. The proposed evaluation strategy encompasses the use of three complementary "quality descriptors": (a) the number of conformations generated by a docking algorithm having a RMSD value lower than the crystal structure resolution (R); (b) a novel consensus-based function defined as "protocol score"; and (c) the interaction energy maps (IEMs) analysis, based on the identification of key ligand-receptor interactions observed in the crystal structures.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25046649     DOI: 10.1021/ci5002857

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  7 in total

1.  Discovery of 2-aminoimidazole and 2-amino imidazolyl-thiazoles as non-xanthine human adenosine A3 receptor antagonists: SAR and molecular modeling studies.

Authors:  Amit N Pandya; Arshi B Baraiya; Hitesh B Jalani; Dhaivat Pandya; Jitendra C Kaila; Sonja Kachler; Veronica Salmaso; Stefano Moro; Karl-Norbert Klotz; Kamala K Vasu
Journal:  Medchemcomm       Date:  2018-03-13       Impact factor: 3.597

2.  Could the presence of sodium ion influence the accuracy and precision of the ligand-posing in the human A2A adenosine receptor orthosteric binding site using a molecular docking approach? Insights from Dockbench.

Authors:  Enrico Margiotta; Giuseppe Deganutti; Stefano Moro
Journal:  J Comput Aided Mol Des       Date:  2018-10-25       Impact factor: 3.686

3.  The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives.

Authors:  Stephanie Federico; Sara Redenti; Mattia Sturlese; Antonella Ciancetta; Sonja Kachler; Karl-Norbert Klotz; Barbara Cacciari; Stefano Moro; Giampiero Spalluto
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

4.  Structural features embedded in G protein-coupled receptor co-crystal structures are key to their success in virtual screening.

Authors:  Thomas Coudrat; Arthur Christopoulos; Patrick Michael Sexton; Denise Wootten
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

5.  A Deep-Learning Approach toward Rational Molecular Docking Protocol Selection.

Authors:  José Jiménez-Luna; Alberto Cuzzolin; Giovanni Bolcato; Mattia Sturlese; Stefano Moro
Journal:  Molecules       Date:  2020-05-27       Impact factor: 4.411

6.  The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles.

Authors:  Lucia Squarcialupi; Marco Betti; Daniela Catarzi; Flavia Varano; Matteo Falsini; Annalisa Ravani; Silvia Pasquini; Fabrizio Vincenzi; Veronica Salmaso; Mattia Sturlese; Katia Varani; Stefano Moro; Vittoria Colotta
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

7.  Pellucidin A promotes antinociceptive activity by peripheral mechanisms inhibiting COX-2 and NOS: In vivo and in silico study.

Authors:  Amanda Pâmela Santos Queiroz; Manolo Cleiton Costa Freitas; José Rogério A Silva; Anderson Bentes Lima; Leila Sawada; Rayan Fidel Martins Monteiro; Ana Carolina Gomes Albuquerque de Freitas; Luís Antônio Loureiro Maués; Alberto Cardoso Arruda; Milton Nascimento Silva; Cristiane Socorro Ferraz Maia; Enéas Andrade Fontes-Júnior; José Luiz M do Nascimento; Mara Silvia P Arruda; Gilmara N T Bastos
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.